Sharekhan

Zim Laboratories Ltd

Wed 30/04/2025,15:43:39 NSE: ZIMLAB

₹ 87.55 -1.46 (-1.64%)
BUY NOW Buy Zim Laboratories Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Zim Laboratories Ltd

Wed 30/04/2025,16:1:0

Zim Laboratories Ltd

Wed 30/04/2025,15:43:39 | NSE : ZIMLAB

₹ 87.55-1.46 (-1.64%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 89.01

Previous Close

₹ 89.01

Volume

19185

Mkt Cap ( Rs. Cr)

₹426.59

High

₹ 89.01

Low

₹ 87.00

52 Week High

₹ 128.90

52 Week Low

₹ 79.49

Book Value Per Share

₹ 49.82

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Zim Laboratories Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

4 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

87.55

100

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

100

Option Chain

Analyzes market sentiment, predicts Zim Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Zim Laboratories - Disclosure under SEBI Takeover Regulations

    29 Apr 2025, 3:30PM Anwar Siraj Daud has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial

  • Zim Laboratories - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    28 Apr 2025, 2:08PM ZIM LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Ag

  • Zim Laboratories - Outcome Of Board Meeting

    28 Apr 2025, 2:03PM In compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you about the outcome of the Board Meeting held on 28/04/2025

  • Zim Laboratories - Change in Auditors

    28 Apr 2025, 2:03PM Zim Laboratories Limited has informed the Exchange regarding Change in Auditors of the company.

  • Zim Laboratories - Disclosure under SEBI Takeover Regulations

    19 Apr 2025, 10:46PM Anwar Siraj Daud has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial

  • Zim Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    11 Apr 2025, 5:20PM As of March 2025, 33.26% is owned by Indian Promoters and 66.74% by Public. <p align=justify> Top five Promoters holding highest number of shares of Z

  • Zim Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2025, 6:51PM Disclosure regarding Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2015

  • Zim Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Apr 2025, 6:49PM Zim Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Zim Laboratories - Press Release

    9 Apr 2025, 2:56PM Zim Laboratories Limited has informed the Exchange regarding a press release dated April 09, 2025, titled ""Global Pharma LL"".

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    9 Apr 2025, 2:55PM Disclosure under Regulation 30 - Press Release for collaboration with Globalpharma L.L.C

  • Zim Laboratories - Acquisition-XBRL

    28 Mar 2025, 8:41PM ZIM Laboratories Limited has informed the Exchange regarding Acquisition

  • Zim Laboratories - Acquisition-XBRL

    28 Mar 2025, 8:32PM ZIM Laboratories Limited has informed the Exchange regarding Acquisition

  • Zim Laboratories - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    28 Mar 2025, 7:58PM ZIM LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Ag

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

    28 Mar 2025, 5:45PM Disclosure under Regulation 30 - Appointment of Secretarial Auditor

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Acquisition

    28 Mar 2025, 5:41PM Disclosure under Regulation 30 - Acquisition

  • Zim Laboratories - Change in Management

    28 Mar 2025, 5:38PM Zim Laboratories Limited has informed the Exchange about change in Management

  • Zim Laboratories - Change in Auditors

    28 Mar 2025, 5:38PM Zim Laboratories Limited has informed the Exchange regarding Change in Auditors of the company.

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

    28 Mar 2025, 5:38PM Disclosure under Regulation 30 - Change in management

  • Zim Laboratories - Acquisition

    28 Mar 2025, 5:38PM Zim Laboratories Limited has informed the Exchange about Acquisition

  • Zim Laboratories - Trading Window-XBRL

    26 Mar 2025, 3:08PM ZIM Laboratories Limited has informed the Exchange about Closure of Trading Window

  • Zim Laboratories - Trading Window

    26 Mar 2025, 3:00PM Zim Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Zim Laboratories - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    19 Mar 2025, 8:35PM ZIM Laboratories Limited has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    19 Mar 2025, 8:01PM Disclosure regarding grant of Marketing Authorisation for Dimethyl Fumarate 120 mg & 240 mg Modified Release Capsules in Portugal, Europe

  • Zim Laboratories - Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

    19 Mar 2025, 7:54PM Zim Laboratories Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

  • Zim Laboratories - Acquisition

    19 Mar 2025, 4:58PM Zim Laboratories Limited has informed the Exchange about the completion of Acquisition of shares

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    19 Mar 2025, 5:06PM Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform you that the company has completed the process of investment of Euro 1,5

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Feb 2025, 4:18PM In compliance with Regulation 30 of SEBI LODR Regulations, 2015 we would like to inform you about the schedule of the Investors / Analysts meet on 05t

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Feb 2025, 4:16PM Zim Laboratories Limited has informed the Exchange about Schedule of meet

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    19 Feb 2025, 7:27PM In compliance with Regulation 30 of SEBI LODR Regulations, 2015 we would like to inform you about the schedule of the Investors / Analysts meet on 22n

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Feb 2025, 7:25PM Zim Laboratories Limited has informed the Exchange about Schedule of meet

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Feb 2025, 1:47PM Zim Laboratories Limited has informed the Exchange about Schedule of meet

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Feb 2025, 1:49PM In compliance with Regulation 30 of SEBI LODR Regulations, 2015 we would like to inform you about the schedule of the Investors / Analysts meet on 18t

  • Zim Laboratories - Copy of Newspaper Publication

    11 Feb 2025, 5:51PM Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

  • Zim Laboratories - Integrated Filing (Financial)

    10 Feb 2025, 9:30PM Integrated Filing (Financial) for the quarter and nine months ended 31st December, 2024

  • Zim Laboratories - Integrated Filing- Financial

    10 Feb 2025, 9:24PM Integrated Filing (Financial) for the quarter and nine months ended 31st December, 2024

  • Zim Laboratories - Q3 & 9M FY25 - Earnings Presentation

    10 Feb 2025, 8:28PM Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed Q3 & 9M FY25 - Earnings Presentation.

  • Zim Laboratories - General Updates

    10 Feb 2025, 8:22PM Zim Laboratories Limited has informed the Exchange about General Updates

  • Zim Laboratories Q3 net profit down 9.94% at Rs 4.35 cr

    10 Feb 2025, 7:50PM The company reported standalone net profit of Rs 4.35 crore for the quarter ended December 31, 2024 as compared to Rs 4.83 crore in the same period la

  • Zim Laboratories - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2024 Is Enclosed Herewith

    10 Feb 2025, 7:40PM Unaudited Financial Results for the quarter and nine months ended 31st December, 2024.

  • Zim Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On 10.02.2025

    10 Feb 2025, 7:30PM In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of D

  • Zim Laboratories - Financial Result Updates

    10 Feb 2025, 7:24PM Zim Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.

  • Zim Laboratories - Board Meeting Intimation

    3 Feb 2025, 8:14PM ZIM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2025 to inter-alia consider and approve the Unaudited Fina

  • Zim Laboratories - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And

    3 Feb 2025, 8:10PM Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 ,inter alia, to consider and
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Zim Laboratories Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 338.3068 253.7463 221.2899 223.4768 228.8653
Liabilities 338.3068 253.7463 221.2899 223.4768 228.8653
Equity 48.7258 48.7258 16.2419 16.2419 16.1807
Gross Profit 40.1024 51.1911 37.934 36.8113 19.7821
Net Profit 16.7555 25.0088 13.0128 5.6162 1.7406
Cash From Operating Activities 11.472 35.2318 47.0265 31.8967 21.2899
NPM(%) 4.58 6.3 3.94 1.84 0.63
Revenue 365.4732 396.5313 329.4937 303.6294 274.3197
Expenses 325.3708 345.3402 291.5597 266.8181 254.5376
ROE(%) 6.9 10.3 5.36 2.31 0.71

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Zim Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 825.75 -1.80 11.65 50.22 1321.50 1.39
Lotus Eye Hospital and Institute Ltd 81.22 -0.17 338.42 183.01 14.01 0.62
Vaishali Pharma Ltd 13.47 -1.82 449.00 94.33 2.76 0.00
Astec Lifesciences Ltd 685.90 -1.03 0.00 172.56 -687.11 0.00

Company Info

The company was incorporates in the state of Maharashtra on 14th February, 1984, under the name and style of Zim Laboratories Ltd. The promoters of the company were Shri Z S Vali, Shri M M Kamal, and Shri I A Trivedi. The company is engaged in manufacturing pharmaceutical product in the form of tablets, capsules and syrups. The company became a Public Ltd. Company by passing special resolution dated 25th January 1992 and fresh certificate of incorporation was obtained from Registrar of Companies, Maharashtra Bombay, on 21st January, 1993. The company commenced commercial production on 7th December 1989 and there was no delay in implementation of the project. 2018 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 -The Company has issued Bonus Shares in the Ratio of 2:1. -Company received Global Nagpur Awards - December 2022. 2023 -Company Received Excellence In Pharma Global Business - April 2023.

The company was incorporates in the state of Maharashtra on 14th February, 1984, under the name and style of Zim Laboratories Ltd. The promoters of the company were Shri Z S Vali, Shri M M Kamal, and Shri I A Trivedi. The company is engaged in manufacturing pharmaceutical product in the form of tablets, capsules and syrups. The company became a Public Ltd. Company by passing special resolution dated 25th January 1992 and fresh certificate of incorporation was obtained from Registrar of Companies, Maharashtra Bombay, on 21st January, 1993. The company commenced commercial production on 7th December 1989 and there was no delay in implementation of the project. 2018 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 -The Company has issued Bonus Shares in the Ratio of 2:1. -Company received Global Nagpur Awards - December 2022. 2023 -Company Received Excellence In Pharma Global Business - April 2023.

Read More

Parent Organisation

Zim Laboratories Ltd.

Founded

14/02/1984

Managing Director

Dr.Anwar Daud

NSE Symbol

ZIMLABEQ

FAQ

The current price of Zim Laboratories Ltd is ₹ 87.55.

The 52-week high for Zim Laboratories Ltd is ₹ 89.01 and the 52-week low is ₹ 87.00.

The market capitalization of Zim Laboratories Ltd is currently ₹ 426.59. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Zim Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Zim Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Zim Laboratories Ltd shares.

The CEO of Zim Laboratories Ltd is Dr.Anwar Daud, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT